Multiple endogenous receptors and extracellular matrix components

Multiple endogenous receptors and extracellular matrix components is a broad pharmacological designation used to describe the multi-target activity of complex biological therapeutics, particularly dehydrated human amnion/chorion membrane (dHACM) and other placental-derived tissues (Source: AdisInsight). Rather than targeting a single molecule, these products function through a multifaceted mechanism involving the delivery of a structural scaffold composed of extracellular matrix (ECM) proteins—including various types of collagen, fibronectin, and laminin—that physically support cell attachment and migration (Source: StatPearls). Simultaneously, they release a diverse array of endogenous growth factors and cytokines that bind to multiple cell-surface receptors to initiate signaling cascades for angiogenesis and tissue repair (Source: Niknejad et al., 2008). This aggregate target profile is primarily associated with the treatment of chronic, non-healing wounds and ophthalmic conditions where a combination of structural support and regenerative signaling is required (Source: Koob et al., 2013). Because it encompasses a heterogeneous mixture of proteins and signaling molecules, it is classified as a non-specific or aggregate target category rather than a distinct molecular entity.

Other names

Extracellular matrix (ECM)Amniotic tissue componentsMulti-receptor interaction complex

The mechanism involves the simultaneous activation of various cell-surface receptors by growth factors and cytokines, alongside the provision of a physical scaffold that supports cell migration, proliferation, and differentiation within the extracellular matrix.